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Metaplastic Cdx2-depleted cells can be very disruptive 
neighbors
In this issue of JEM, Balbinot et al. (https ://doi .org /10 .1084 /jem .20170934) describe an original mechanism where Cdx2 
inactivation regulates intestinal metaplastic to neoplastic transition in a paracrine fashion. Surprisingly, the target cells are 
neighboring “normal” Cdx2-positive cells.
The homeodomain or homeobox pro-
tein family are transcription factors 
that contain a conserved DNA-binding 
domain that play a vital role in spatial 
patterning during embryogenesis. Their 
function has been first described in 
Drosophila (Scott and O’Farrell, 1986) 
and is conserved throughout evolution 
to vertebrates (De Robertis et al., 1989; 
Wright et al., 1989). Cdx2 is a home-
odomain protein whose expression in 
the murine late embryo and adult is 
confined to the epithelium of the intes-
tine. It has a pivotal role in the establish-
ment of endodermal anterior-posterior 
(AP) asymmetry and more specifically 
intestinal identity. Cdx2-null mice are 
not viable and die before gastrulation. 
Heterozygote Cdx2-deficient mice are 
viable and present developmental ab-
normalities such as stunted growth or 
rib malformation (Chawengsaksophak 
et al., 1997). Mosaic conditional Cdx2 
knockout in the adult intestine results in 
impairment of stem cell differentiation 
with gradual loss of villous morphology 
and formation of cystic vesicles. When 
aged, these mice present cecal polyps 
with Cdx2-negative regions displaying 
gastric features (Stringer et al., 2012).
Motivated by the recent classifi-
cation of human colorectal cancers into 
subgroups based on transcriptional sig-
natures Balbinot and colleagues revisit 
the mosaic Cdx2 conditional knockout 
mouse model described above (Stringer 
et al., 2012). Strong CDX2 down-regu-
lation was shown to be associated with 
one particular subtype characterized 
by serrated precursor neoplasia, stromal 
infiltration, stem-cell–like features, and 
poor prognosis (Marisa et al., 2013). 
In the current mouse study, Balbinot 
et al. (2018) found the expected, cecal 
polypoid lesions with some degree of 
gastric metaplasia. This was confirmed 
by transcriptomic analysis where in-
testinal markers such as Cdx1 or Alpi 
were down-regulated and several gastric 
markers (e.g., Tff1/2, Cldn18, Muc1/6) 
were up-regulated. The absence of other 
typical gastric markers (e.g., Sox2 or 
Muc5a) suggests incomplete metapla-
sia. Often, metaplasia persistence can 
lead to the development of dysplasia 
and sporadically to neoplasia (Giroux 
and Rustgi, 2017). However, this does 
not seem to be the case for Cdx2-de-
ficient gastric metaplasia, despite the 
tumor predisposition associated with its 
heterozygous loss (Chawengsaksophak 
et al., 1997). To further test the protu-
morigenic role of Cdx2 deficiency, the 
authors next crossed the mosaic Cdx2 
inactivation model to mice deficient 
in the intestinal tumor suppressor gene 
Apc. These Apc+/Δ14 mice develop ade-
nomas and a few adenocarcinomas along 
the intestinal tract. These compound 
mice had a reduced lifespan with more 
lesions in the small intestine, colon, and 
cecum when compared with mice with 
only the Apc+/Δ14 mutation. The lesions 
displayed a mixed phenotype combining 
the gastric metaplasia and some patho-
logical features reminiscent of carcino-
mas. Transcriptomic analysis showed 
an up-regulation of the Wnt pathway 
as well as gastric-type genes. However, 
the most striking results were obtained 
when the authors performed lineage 
tracing of the cells that had undergone 
Cdx2 inactivating recombination by 
crossing a conditionally activated flu-
orescent cassette (tdTomato) into the 
model. Surprisingly, they observed a 
total exclusion of red cells (Cdx2 nega-
tive) from tumor regions displaying high 
nuclear β-catenin. This observation led 
the authors to suggest that Cdx2-neg-
ative cells generate a tumor-prone mi-
croenvironment that induces neoplastic 
conversion of Cdx2 intact cells. By this 
definition, Cdx2 is acting as a “non–
cell-autonomous tumor suppressor.”
In the search for a mechanism, 
Balbinot et al. (2018) looked again at 
the transcriptome of gastric metapla-
sia present in the cecum. They found 
up-regulation of several cytokines and 
chemokines previously associated with 
malignancy. Moreover, they show that 
NF-κB, a key node for cytokine and 
chemokine signaling, was translocated 
and activated only in the nucleus of 
Cdx2-positive cells present at the sur-
face epithelium adjacent to the met-
aplastic lesions. These Cdx2-positive 
cells displayed high levels of nitric oxide 
synthase (iNOS), a protein previously 
shown to induce genomic instability and 
accelerate allelic loss of Apc, leading to 
enhanced tumor development (Shaked 
et al., 2012). To test the therapeutic 
relevance of these findings the authors 
treated the compound mice with ami-
noguanidine (AG), an iNOS inhibitor, 
which reduced the tumor load. Inter-
estingly, there was no effect in Apc+/Δ14 
mice treated with AG, strengthening 
the putative role of Cdx2 inactivation 
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2in the induction of nitrosative stress in 
Cdx2-positive neighboring cells.
Over many years, there has been a 
huge effort on understanding how the 
microenvironment created by the stroma 
influences tumor initiation, progression, 
and therapeutic responses. However, less 
is known about the interactions within 
the epithelium. This work adds a new 
perspective on how neighboring meta-
plastic epithelial cells can shape the tran-
sition between different tissue states and 
in fine cancer initiation by otherwise 
“normal” cells. The “field cancerization” 
concept (Curtius et al., 2018) may need 
to be refined to include a mechanism 
whereby cancers initiate from cells re-
siding at clonal boundaries adjacent to 
epithelial cells expressing alternative 
tumor promoting programs. In this case 
a Cdx2-negative metaplastic clone bor-
dering a Cdx2-positive Apc+/Δ14 clone 
(see figure).
One of the pending questions Bal-
binot et al. (2018) did not address relates 
to why Cdx2-negative cells do not them-
selves initiate neoplasia. Speculatively, the 
answer may lie in the way the intestinal 
epithelium is renewed. Upon Cdx2 pat-
terned differentiation, cells retain Cdx2 
expression and move along the crypt 
toward the lumen where they are shed. 
During this terminal differentiation and 
removal from the epithelium, they shut 
down essential functions such as the 
DNA damage response. This contrasts to 
stem cells that need to ensure genomic 
stability. The soft spot for neoplastic tran-
sition is likely to be the transition state 
where cells are still cycling and differenti-
ating, especially in premalignant cells dis-
playing oncogenic mutations (Schwitalla 
et al., 2013). Conceivably, aberrant differ-
entiation associated with partial metapla-
sia allows programs for genomic stability 
to be maintained.
The association between CDX2 
inactivation and the serrated-type car-
cinoma has focused attention on the 
different molecular pathways driving 
this pathology. A significant majority of 
these lesions do not display activation of 
the WNT pathway, reflecting the lower 
prevalence of somatic mutations in APC 
or β-Catenin (Sakamoto et al., 2017). 
Instead, these lesions often have muta-
tions in BRAF, a key MAPK pathway 
mediator. Two recent independent stud-
ies using mouse models show that com-
bined conditional Cdx2 inactivation and 
expression of mutant Braf (BrafV600E) 
promoted serrated benign and invasive 
tumors (Sakamoto et al., 2017; Tong et 
al., 2017). One of these studies provides 
evidence that the differentiation status 
of the normal colonic mucosa is a good 
predictor of susceptibility to serrated 
tumors (Tong et al., 2017). A possible 
way of unifying all these observations 
would be that CDX2-deficient cells 
in the “normal” or metaplastic mucosa 
preferentially favor the emergence of 
BRAF mutant serrated lesions cell au-
tonomously and WNT-driven lesions in 
a non–cell-autonomous fashion.
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